Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
After a week of stress, mice show changes in how their brains process sound, reducing how well they perceive loud noises, ...
Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the ...
Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...
After a week of stress, mice show changes in how their brains process sound, reducing how well they perceive loud noises, ...
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...
News Medical on MSN3d
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer TherapyAriceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
Fintel on MSN8d
Wolfe Research Initiates Coverage of Crinetics Pharmaceuticals (CRNX) with Peer Perform RecommendationFintel reports that on February 4, 2025, Wolfe Research initiated coverage of Crinetics Pharmaceuticals (NasdaqGS:CRNX) with ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...
After a week of stress, mice show changes in how their brains process sound, reducing how well they perceive loud noises, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback